Karyopharm to Report Third Quarter 2024 Financial Results on November 5, 2024
Karyopharm Therapeutics (Nasdaq: KPTI), a commercial-stage pharmaceutical company focused on novel cancer therapies, has scheduled its third quarter 2024 financial results announcement for Tuesday, November 5, 2024. The management team will host a conference call and audio webcast at 8:00 a.m. ET on the same day. The presentation will include financial results and company updates, with dial-in numbers provided for both local and international participants. A live webcast with slides will be available on the company's investor website, with an archived version accessible approximately two hours after the event.
Karyopharm Therapeutics (Nasdaq: KPTI), un'azienda farmaceutica in fase commerciale focalizzata su nuove terapie per il cancro, ha programmato l'annuncio dei suoi risultati finanziari del terzo trimestre 2024 per martedì 5 novembre 2024. Il team dirigenziale ospiterà una conferenza telefonica e un webcast audio alle 8:00 a.m. ET dello stesso giorno. La presentazione includerà risultati finanziari e aggiornamenti aziendali, con numeri di accesso forniti per i partecipanti locali e internazionali. Un webcast dal vivo con diapositive sarà disponibile sul sito web per gli investitori dell'azienda, con una versione archiviata accessibile circa due ore dopo l'evento.
Karyopharm Therapeutics (Nasdaq: KPTI), una empresa farmacéutica en etapa comercial centrada en nuevas terapias contra el cáncer, ha programado el anuncio de sus resultados financieros del tercer trimestre de 2024 para el martes 5 de noviembre de 2024. El equipo de gestión llevará a cabo una conferencia telefónica y un webcast de audio a las 8:00 a.m. ET el mismo día. La presentación incluirá resultados financieros y actualizaciones de la empresa, con números de acceso proporcionados tanto para participantes locales como internacionales. Un webcast en vivo con diapositivas estará disponible en el sitio web de inversores de la compañía, con una versión archivada accesible aproximadamente dos horas después del evento.
Karyopharm Therapeutics (Nasdaq: KPTI)는 새로운 암 치료에 중점을 둔 상업 단계의 제약 회사로, 2024년 3분기 재무 결과 발표를 2024년 11월 5일 화요일로 예정했습니다. 경영진 팀은 같은 날 오전 8시 (ET)에 전화 회의 및 오디오 웹 캐스트를 주최할 예정입니다. 발표에는 재무 결과와 회사 업데이트가 포함되며, 현지 및 국제 참가자를 위한 접속 번호가 제공됩니다. 슬라이드가 포함된 라이브 웹캐스트는 회사의 투자자 웹사이트에서 제공되며, 이벤트 종료 약 두 시간 후에는 아카이브 버전도 이용 가능합니다.
Karyopharm Therapeutics (Nasdaq: KPTI), une société pharmaceutique en phase commerciale axée sur de nouvelles thérapies contre le cancer, a programmé l'annonce de ses résultats financiers du troisième trimestre 2024 pour le mardi 5 novembre 2024. L'équipe de direction organisera une conférence téléphonique et un webinaire audio le même jour à 8h00 ET. La présentation comprendra les résultats financiers et des mises à jour sur l'entreprise, avec des numéros d'appel fournis pour les participants locaux et internationaux. Un webinaire en direct avec des diapositives sera disponible sur le site web des investisseurs de la société, une version archivée étant accessible environ deux heures après l'événement.
Karyopharm Therapeutics (Nasdaq: KPTI), ein kommerzielles Pharmaunternehmen, das sich auf neuartige Krebstherapien konzentriert, hat die Bekanntgabe seiner Finanzergebnisse für das dritte Quartal 2024 für Dienstag, den 5. November 2024, angesetzt. Das Managementteam wird am gleichen Tag um 8:00 Uhr ET eine Telefonkonferenz und einen Audio-Webcast veranstalten. Die Präsentation wird Finanzergebnisse und Unternehmensaktualisierungen enthalten, wobei Zugangsdaten sowohl für lokale als auch internationale Teilnehmer bereitgestellt werden. Ein Live-Webcast mit Folien wird auf der Website des Unternehmens für Investoren verfügbar sein, und eine aufgezeichnete Version wird etwa zwei Stunden nach der Veranstaltung zugänglich sein.
- None.
- None.
-- Conference Call Scheduled for Tuesday, November 5, 2024, at 8:00 a.m. ET --
To access the conference call, please dial (800) 836-8184 (local) or (646) 357-8785 (international) at least 10 minutes prior to the start time and ask to be joined into the Karyopharm Therapeutics call. A live audio webcast of the call, along with accompanying slides, will be available under "Events & Presentations" in the Investor section of the Company's website, http://investors.karyopharm.com/events-presentations. An archived webcast will be available on the Company's website approximately two hours after the event.
About Karyopharm Therapeutics
Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is a commercial-stage pharmaceutical company whose dedication to pioneering novel cancer therapies is fueled by a belief in the extraordinary strength and courage of patients with cancer. Since its founding, Karyopharm has been an industry leader in oral compounds that address nuclear export dysregulation, a fundamental mechanism of oncogenesis. Karyopharm's lead compound and firstinclass, oral exportin 1 (XPO1) inhibitor, XPOVIO® (selinexor), is approved in the
XPOVIO® and NEXPOVIO® are registered trademarks of Karyopharm Therapeutics Inc. Any other trademarks referred to in this release are the property of their respective owners.
View original content to download multimedia:https://www.prnewswire.com/news-releases/karyopharm-to-report-third-quarter-2024-financial-results-on-november-5-2024-302292411.html
SOURCE Karyopharm Therapeutics Inc.
FAQ
When will Karyopharm (KPTI) report Q3 2024 earnings?
What time is Karyopharm's (KPTI) Q3 2024 earnings call?
How can I access Karyopharm's (KPTI) Q3 2024 earnings call?
